CN Patent

CN101252920A — 包含替诺福韦、表面活性剂、依法韦仑和恩曲他滨的稳定固定剂量的单位制剂

Assigned to Gilead Sciences Inc · Expires 2008-08-27 · 18y expired

What this patent protects

本发明提供了包含依法韦仑、恩曲他滨和替诺福韦DF的作为多成分单位口服剂型的新药物产品，成分1包含替诺福韦DF(和任选恩曲他滨)且成分2包含依法韦仑，其中成分1和2在稳定的结构中。在优选的实施方案中，通过干法制粒制备成分1。

USPTO Abstract

本发明提供了包含依法韦仑、恩曲他滨和替诺福韦DF的作为多成分单位口服剂型的新药物产品，成分1包含替诺福韦DF(和任选恩曲他滨)且成分2包含依法韦仑，其中成分1和2在稳定的结构中。在优选的实施方案中，通过干法制粒制备成分1。

Drugs covered by this patent

Patent Metadata

Patent number
CN101252920A
Jurisdiction
CN
Classification
—
Expires
2008-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.